New Therapies in ALS: Fecal Microbiota Transplant (FMT), Transcranial Magnetic Stimulation
BodyScience Life BodyScience Life
136K subscribers
71,849 views
848

 Published On Jun 27, 2024

Webinar June 27th 2024
(Subtitulos disponibles en Español)
New Therapies in ALS: Fecal Microbiota Transplant FMT, Transcranial Magnetic Stimulation
Summary
🧑‍🔬 Introduction to BodyScience: Amy Jaramillo introduces herself and BodyScience's focus on neurodegenerative diseases, mentioning new developments in the field.
🧬 New Strategies: Emphasizes the importance of new treatments and research in ALS, Parkinson's, and Alzheimer's, and the availability of these treatments.
💡 Emerging Therapies:
Monoclonal Antibodies: Discusses recent research and their potential for treating neurodegenerative diseases.
Fecal Microbiota Transplant (FMT): Highlights recent studies showing significant improvements in ALS patients.
Transcranial Direct Current Stimulation (tDCS): Describes its potential to reconfigure brain pathways even after pathogen eradication.
Filgrastim: Explains its use in mobilizing bone marrow stem cells and reducing neuroinflammation.
🧠 Astrocyte Protocol: Describes the shift in focus from motor neurons to glial cells and astrocytes, showing promising results in ALS patients.
🔬 Research and Innovations: Stresses the continuous advancements and the clinic's role in implementing these therapies.
🏥 Patient Stories: Shares success stories of patients showing significant improvements with new treatments.

Insights Based on Numbers
Increase in Muscle Strength: Patients showed an increase in muscle circumference (5-9 cm) after FMT.
Functional Improvement Scores: ALS Functional Rating Scale scores improved from 15 to 20 in one patient and from 15 to 23 in another after FMT.
Reduction in Ventilator Dependence: FMT patients showed significant reduction in ventilator use, with one patient breathing independently after four weeks.

Example Exploratory Questions
1. How does fecal microbiota transplant (FMT) help ALS patients regain muscle strength and improve breathing?
2. What role do astrocytes play in neurodegenerative diseases, and how does the Astrocyte Protocol target these cells?
3. How can monoclonal antibodies be used to treat neurodegenerative diseases like Alzheimer's and Parkinson's?

BodyScience
5975 Sunset Drive Suite 100
South Miami FL 33143

PHONE: 305-901-5888
www.bodyscience.life
email: [email protected]

ALS Page
https://www.bodyscience.life/als-program

Registration
https://www.bodyscience.life/registra...

FB Group
  / 1008584079506823  

Youtube
   / @bodysciencelife2562  

show more

Share/Embed